Curaleaf has filed a Notice of Variation to increase its AM bid for Aurora Cannabis, now valued at US$6.00 per share based on current share prices. This move increases the proposed deal's premium while excluding balance sheet cash, though the expanded generosity is met with Aurora's refusal to engage on the higher valuation.